3EBMT Leiden Study Unit ▲ Sign in to save

• ▲ Gloria Tridello

  European Society for Blood and Marrow Transplantation Medicine
  5.2k

  citations

  35

  h-index

  23

  Aachen papers
• ▲ Linda Köster

  Leiden University · National Taiwan University Medicine
  1.84k

  citations

  23

  h-index

  109

  Aachen papers
• ▲ Nina Simone Knelange

  European Society for Blood and Marrow Transplantation Medicine
  1.06k

  citations

  17

  h-index

  44

  Aachen papers
• ▲ Dirk‐Jan Eikema

  European Society for Blood and Marrow Transplantation Medicine
  1.02k

  citations

  19

  h-index

  57

  Aachen papers
• ▲ Nienke Zinger

  Netherlands Institute for Health Services Research Medicine
  229

  citations

  8

  h-index

  14

  Aachen papers
• ▲ Laurien G.A. Baaij

  Leiden University · European Society for Blood and Marrow Transplantation Medicine
  115

  citations

  4

  h-index

  15

  Aachen papers
• ▲ Brian Piepenbroek

  European Society for Blood and Marrow Transplantation Medicine
  93

  citations

  5

  h-index

  17

  Aachen papers
• ▲ Joe Tuffnell

  European Society for Blood and Marrow Transplantation Medicine
  75

  citations

  4

  h-index

  17

  Aachen papers
• ▲ Linda Kostner

  European Society for Blood and Marrow Transplantation Medicine
  1

  citations

  1

  h-index

  2

  Aachen papers
• ▲ Nadia Erazo

  European Society for Blood and Marrow Transplantation Medicine
  0

  citations

  0

  h-index

  1

  Aachen papers

10 results

• Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT

  2024 Blood Advances article Medicine Hematopoietic Stem Cell Transplantation Open access

  67

  citations
• Alternative donor transplantation for severe aplastic anemia: a comparative study of the SAAWP EBMT

  2024 Blood article Medicine Hematopoietic Stem Cell Transplantation Open access

  31

  citations
• Allogeneic Hematopoietic Cell Transplantation for Vexas Syndrome: Results of a Multicenter Study from the Chronic Malignancies and Autoimmune Disease Working Parties of the EBMT

  2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

  5

  citations
• Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplantation for T-Cell Prolymphocytic Leukemia - a Study on Behalf of the Chronic Malignancies Working Party of the EBMT

  2024 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation Open access

  3

  citations
• Transplant Outcomes for Acute Myeloid Leukemia or Myelodysplastic Syndromes Secondary to Acquired Aplastic Anemia or Paroxysmal Nocturnal Hemoglobinuria: A Report from the EBMT Severe Aplastic Anemia Working Party

  2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

  2

  citations
• Thymoglobuline and grafalon show comparable transplant outcomes in patients with aplastic anemia undergoing allogeneic stem cell transplantation: A multicenter EBMT saawp study of 1603 patients

  2025 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation Open access

  0

  citations
• Autologous Hematopoietic Cell Transplantation for T-Cell Prolymphocytic Leukemia - a Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT

  2022 Blood article Medicine Hematopoietic Stem Cell Transplantation Open access

  0

  citations
• Gvhd Prophylaxis Incorporating Methotrexate in Allo-HCT for Chronic Myeloid Malignancies and sAML: A Retrospective Analysis from the Cmwp of the EBMT

  2022 Blood article Medicine Hematopoietic Stem Cell Transplantation

  0

  citations
• Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) in Patients with Calr-Mutated Myelofibrosis

  2022 Blood article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment

  0

  citations
• Autologous Peripheral Blood Stem Cell Mobilisation Techniques, Stem Cell Yields and Practice Variation-By-Country in Patients with Myeloma Undergoing First Autologous Stem Cell Transplants in EBMT Centres between 2012 and 2021

  2022 Blood article Medicine Multiple Myeloma Research and Treatments

  0

  citations
• Allogeneic Hematopoietic Cell Transplantation in Patients with Therapy-Related Myeloid Neoplasm Following Treatment for Lymphoma: A Study of the Chronic Malignancies Working Party of the EBMT

  2022 Blood article Medicine Hematopoietic Stem Cell Transplantation

  0

  citations
• Long Term Outcomes and Renal Response Following Autologous Stem Cell Transplantation for Light Chain Deposition Disease:a Retrospective Study on Behalf of the Cmwp of the EBMT

  2023 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes

  0

  citations
• Impact of Post-Transplant Cyclophosphamide (PTCY)-Based Prophylaxis in Matched Sibling Donor Allo-HCT for Patients with Myelodysplastic Syndrome: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

  2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

  0

  citations
• Conditioning Intensity in Patients Aged > 50 Years Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrom: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

  2023 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation Open access

  0

  citations
• Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study

  2023 Blood conference-abstract Medicine Multiple Myeloma Research and Treatments

  0

  citations
• Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome in Young Adults. a Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT

  2024 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

  0

  citations
• Decreased Chronic GvHD with Post-Transplant Cyclophosphamide (PTCY) Compared to ATG in Patients with Myelofibrosis Allografted with Unrelated Donor: A Study from the Chronic Malignancies Working Party of the EBMT

  2024 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation Open access

  0

  citations
• Central Nervous System Disorders (CNSD) Following Hematopoietic Stem Cell Transplantation (HSCT): A Prospective Study from the Infectious Diseases Working Party (IDWP) and the Transplant Complications Working Party (TCWP), European Society of Blood and Marrow Transplantation (EBMT)

  2024 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation Open access

  0

  citations

18 results